SBI Securities’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39K Hold
251
﹤0.01% 2685
2026
Q1
$1.51K Hold
251
﹤0.01% 2504
2025
Q4
$1.01K Buy
251
+89
+55% +$330 ﹤0.01% 2643
2025
Q3
$341 Hold
162
﹤0.01% 3132
2025
Q2
$279 Buy
162
+109
+206% +$178 ﹤0.01% 3203
2025
Q1
$90 Hold
53
﹤0.01% 3480
2024
Q4
$118 Buy
+53
New +$125 ﹤0.01% 3412

Other funds holding NERV

SBI Securities's NERV Position: Q2 2026 in Review

SBI Securities held its Minerva Neurosciences (NERV) position steady in Q2 2026 at 251 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

SBI Securities first reported a position in NERV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.51K in Q1 2026. 11 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • SBI Securities held 251 shares of Minerva Neurosciences worth $1.39K as of Q2 2026.
  • SBI Securities left its Minerva Neurosciences share count unchanged in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2685 holding.
  • SBI Securities first reported a position in Minerva Neurosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Minerva Neurosciences position peaked at $1.51K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.